AtriCure (ATRC) Tops Q1 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Revenue Growth %: +12.5%
Financial Fact:
Loss from operations: -6.29M
Today's EPS Names:
ORPB, PBCO, SICP, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q1 EPS of ($0.20), $0.04 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $54 million versus the consensus estimate of $52.45 million.
GUIDANCE:
Management is updating revenue guidance for 2019 to a range of $222 million to $228 million, corresponding to growth of 10% to 13% for the year, and maintaining expectations for positive full-year adjusted EBITDA between $0 and $3 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bloom Energy shares fall despite beating Q3 estimates
- Consumer Portfolio Services (CPSS) Reports Q3 EPS of $0.30
- MaxLinear (MXL) Tops Q3 EPS by 6c; Offers Outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
